Published in AIDS Weekly, May 19th, 1997
The strategy, still on the drawing board, is based on new insights into HIV gained from the identification of cellular chemokine receptors as necessary for HIV infectivity.
Harvard researcher Craig Gerard described these studies - and their implications for vaccine strategies - in a plenary presentation to the 9th Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS (NCVDG), held May 4-7, 1997, in Bethesda, Maryland.
Gerard suggested that HIV fuses to cells only after a two-step process. In step one,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1997-05-19)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.